These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72. The incidence of Clostridium difficile-associated and non-C. difficile-associated diarrhea after use of gatifloxacin and levofloxacin in an acute-care facility. Khurana A; Vinayek N; Recco RA; Go ES; Zaman MM Clin Infect Dis; 2004 Aug; 39(4):602-3. PubMed ID: 15356836 [No Abstract] [Full Text] [Related]
73. New drugs and dosage forms. Am J Health Syst Pharm; 2004 Jul; 61(14):1432. PubMed ID: 15332686 [No Abstract] [Full Text] [Related]
76. Follow-on rifaximin for the prevention of recurrence following standard treatment of infection with von Cube MK; Schumacher M; Wolkewitz M; Gut; 2020 Feb; 69(2):398-400. PubMed ID: 30593454 [No Abstract] [Full Text] [Related]
77. Efficacy of oral vancomycin in primary prevention of Clostridium Difficile infection in elderly patients treated with systemic antibiotic therapy. Papic N; Maric LS; Vince A Infect Dis (Lond); 2018 Jun; 50(6):483-486. PubMed ID: 29323607 [No Abstract] [Full Text] [Related]
78. Prevention of travellers' diarrhoea: where and who? Ruiz J; Pons MJ Lancet Infect Dis; 2013 Nov; 13(11):911-2. PubMed ID: 24012318 [No Abstract] [Full Text] [Related]